Qyuns Therapeutics Co., Ltd.
Qyuns Therapeutics Co., Ltd. 2509.HK Peers
See (2509.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2509.HK | HK$14.80 | +5.56% | 3.3B | -8.55 | -HK$1.73 | N/A |
| 1801.HK | HK$73.15 | +1.18% | 120.7B | -1045.00 | -HK$0.07 | N/A |
| 2269.HK | HK$24.65 | -1.00% | 100.3B | 29.00 | HK$0.85 | N/A |
| 1177.HK | HK$4.55 | +0.44% | 81.4B | 41.36 | HK$0.11 | +1.32% |
| 9926.HK | HK$82.25 | +0.37% | 73.7B | -124.62 | -HK$0.66 | N/A |
| 1530.HK | HK$20.20 | +3.91% | 47.6B | 21.72 | HK$0.93 | +1.24% |
| 3759.HK | HK$15.40 | -2.28% | 42.7B | 13.75 | HK$1.12 | +1.67% |
| 6821.HK | HK$71.40 | +0.99% | 33.9B | 23.26 | HK$3.07 | +2.53% |
| 9688.HK | HK$29.65 | +3.85% | 32.6B | -13.48 | -HK$2.20 | N/A |
| 1877.HK | HK$21.35 | -0.23% | 32.1B | -13.77 | -HK$1.55 | N/A |
Stock Comparison
2509.HK vs 1801.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1801.HK has a market cap of 120.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1801.HK trades at HK$73.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1801.HK's P/E ratio is -1045.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1801.HK's ROE of -0.01%. Regarding short-term risk, 2509.HK is more volatile compared to 1801.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2269.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2269.HK has a market cap of 100.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2269.HK trades at HK$24.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2269.HK's P/E ratio is 29.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2269.HK's ROE of +0.06%. Regarding short-term risk, 2509.HK is more volatile compared to 2269.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1177.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1177.HK has a market cap of 81.4B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1177.HK trades at HK$4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1177.HK's P/E ratio is 41.36. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1177.HK's ROE of +0.11%. Regarding short-term risk, 2509.HK is more volatile compared to 1177.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 9926.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 9926.HK has a market cap of 73.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 9926.HK trades at HK$82.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 9926.HK's P/E ratio is -124.62. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 9926.HK's ROE of -0.09%. Regarding short-term risk, 2509.HK is more volatile compared to 9926.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1530.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1530.HK has a market cap of 47.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1530.HK trades at HK$20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1530.HK's P/E ratio is 21.72. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1530.HK's ROE of +0.14%. Regarding short-term risk, 2509.HK is more volatile compared to 1530.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 3759.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 3759.HK has a market cap of 42.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 3759.HK trades at HK$15.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 3759.HK's P/E ratio is 13.75. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 3759.HK's ROE of +0.14%. Regarding short-term risk, 2509.HK is more volatile compared to 3759.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6821.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6821.HK has a market cap of 33.9B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6821.HK trades at HK$71.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6821.HK's P/E ratio is 23.26. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6821.HK's ROE of +0.06%. Regarding short-term risk, 2509.HK is more volatile compared to 6821.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 9688.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 9688.HK has a market cap of 32.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 9688.HK trades at HK$29.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 9688.HK's P/E ratio is -13.48. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 9688.HK's ROE of -0.33%. Regarding short-term risk, 2509.HK is more volatile compared to 9688.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1877.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1877.HK has a market cap of 32.1B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1877.HK trades at HK$21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1877.HK's P/E ratio is -13.77. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1877.HK's ROE of -0.20%. Regarding short-term risk, 2509.HK is more volatile compared to 1877.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1548.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1548.HK has a market cap of 31.4B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1548.HK trades at HK$14.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1548.HK's P/E ratio is -22.15. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1548.HK's ROE of -0.06%. Regarding short-term risk, 2509.HK is less volatile compared to 1548.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2096.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2096.HK has a market cap of 31B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2096.HK trades at HK$12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2096.HK's P/E ratio is 39.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2096.HK's ROE of +0.10%. Regarding short-term risk, 2509.HK is more volatile compared to 2096.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 9995.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 9995.HK has a market cap of 29.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 9995.HK trades at HK$46.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 9995.HK's P/E ratio is -15.49. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 9995.HK's ROE of -0.58%. Regarding short-term risk, 2509.HK is more volatile compared to 9995.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2696.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2696.HK has a market cap of 24.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2696.HK trades at HK$45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2696.HK's P/E ratio is 27.64. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2696.HK's ROE of +0.29%. Regarding short-term risk, 2509.HK is more volatile compared to 2696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6855.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6855.HK has a market cap of 19.2B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6855.HK trades at HK$55.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6855.HK's P/E ratio is -37.95. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6855.HK's ROE of -0.79%. Regarding short-term risk, 2509.HK is more volatile compared to 6855.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 9969.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 9969.HK has a market cap of 17.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 9969.HK trades at HK$11.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 9969.HK's P/E ratio is -42.07. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 9969.HK's ROE of -0.06%. Regarding short-term risk, 2509.HK is more volatile compared to 9969.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1952.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1952.HK has a market cap of 15.5B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1952.HK trades at HK$47.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1952.HK's P/E ratio is -13.50. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1952.HK's ROE of -0.24%. Regarding short-term risk, 2509.HK is more volatile compared to 1952.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2162.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2162.HK has a market cap of 13.2B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2162.HK trades at HK$47.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2162.HK's P/E ratio is -22.23. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2162.HK's ROE of -0.20%. Regarding short-term risk, 2509.HK is more volatile compared to 2162.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6826.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6826.HK has a market cap of 12.1B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6826.HK trades at HK$26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6826.HK's P/E ratio is 13.42. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6826.HK's ROE of +0.07%. Regarding short-term risk, 2509.HK is more volatile compared to 6826.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2171.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2171.HK has a market cap of 11B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2171.HK trades at HK$19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2171.HK's P/E ratio is -12.23. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2171.HK's ROE of +0.00%. Regarding short-term risk, 2509.HK is more volatile compared to 2171.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 0775.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 0775.HK has a market cap of 8.5B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 0775.HK trades at HK$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 0775.HK's P/E ratio is -88.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 0775.HK's ROE of -0.03%. Regarding short-term risk, 2509.HK is more volatile compared to 0775.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2157.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2157.HK has a market cap of 8.4B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2157.HK trades at HK$5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2157.HK's P/E ratio is -19.62. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2157.HK's ROE of -0.51%. Regarding short-term risk, 2509.HK is less volatile compared to 2157.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1672.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1672.HK has a market cap of 8.1B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1672.HK trades at HK$7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1672.HK's P/E ratio is -23.18. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1672.HK's ROE of -0.15%. Regarding short-term risk, 2509.HK is more volatile compared to 1672.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 9966.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 9966.HK has a market cap of 7.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 9966.HK trades at HK$7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 9966.HK's P/E ratio is 44.28. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 9966.HK's ROE of +0.10%. Regarding short-term risk, 2509.HK is more volatile compared to 9966.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2315.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2315.HK has a market cap of 7.4B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2315.HK trades at HK$17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2315.HK's P/E ratio is 194.44. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2315.HK's ROE of -0.19%. Regarding short-term risk, 2509.HK is more volatile compared to 2315.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2142.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2142.HK has a market cap of 6.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2142.HK trades at HK$7.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2142.HK's P/E ratio is 265.33. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2142.HK's ROE of +0.02%. Regarding short-term risk, 2509.HK is more volatile compared to 2142.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2256.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2256.HK has a market cap of 6.5B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2256.HK trades at HK$9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2256.HK's P/E ratio is 239.75. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2256.HK's ROE of +0.01%. Regarding short-term risk, 2509.HK is more volatile compared to 2256.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1477.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1477.HK has a market cap of 6.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1477.HK trades at HK$7.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1477.HK's P/E ratio is -18.24. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1477.HK's ROE of -0.08%. Regarding short-term risk, 2509.HK is more volatile compared to 1477.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1541.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1541.HK has a market cap of 5.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1541.HK trades at HK$14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1541.HK's P/E ratio is -15.49. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1541.HK's ROE of -0.49%. Regarding short-term risk, 2509.HK is less volatile compared to 1541.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2616.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2616.HK has a market cap of 5.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2616.HK trades at HK$3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2616.HK's P/E ratio is -48.87. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2616.HK's ROE of -0.22%. Regarding short-term risk, 2509.HK is more volatile compared to 2616.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6660.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6660.HK has a market cap of 4.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6660.HK trades at HK$3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6660.HK's P/E ratio is -15.44. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6660.HK's ROE of -0.08%. Regarding short-term risk, 2509.HK is more volatile compared to 6660.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2179.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2179.HK has a market cap of 4.1B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2179.HK trades at HK$8.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2179.HK's P/E ratio is -6.77. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2179.HK's ROE of -0.82%. Regarding short-term risk, 2509.HK is more volatile compared to 2179.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1167.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1167.HK has a market cap of 4B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1167.HK trades at HK$5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1167.HK's P/E ratio is -23.23. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1167.HK's ROE of -0.17%. Regarding short-term risk, 2509.HK is more volatile compared to 1167.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1873.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1873.HK has a market cap of 3.7B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1873.HK trades at HK$1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1873.HK's P/E ratio is 25.43. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1873.HK's ROE of +0.04%. Regarding short-term risk, 2509.HK is more volatile compared to 1873.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2487.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2487.HK has a market cap of 3.2B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2487.HK trades at HK$10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2487.HK's P/E ratio is -6.81. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2487.HK's ROE of -0.40%. Regarding short-term risk, 2509.HK is less volatile compared to 2487.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 3681.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 3681.HK has a market cap of 2.5B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 3681.HK trades at HK$2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 3681.HK's P/E ratio is -11.21. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 3681.HK's ROE of -0.79%. Regarding short-term risk, 2509.HK is less volatile compared to 3681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1521.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1521.HK has a market cap of 2.4B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1521.HK trades at HK$1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1521.HK's P/E ratio is 59.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1521.HK's ROE of +0.00%. Regarding short-term risk, 2509.HK is more volatile compared to 1521.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6996.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6996.HK has a market cap of 2.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6996.HK trades at HK$3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6996.HK's P/E ratio is -6.52. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6996.HK's ROE of -0.35%. Regarding short-term risk, 2509.HK is more volatile compared to 6996.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2181.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2181.HK has a market cap of 2B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2181.HK trades at HK$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2181.HK's P/E ratio is -16.17. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2181.HK's ROE of -1.25%. Regarding short-term risk, 2509.HK is more volatile compared to 2181.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6622.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6622.HK has a market cap of 1.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6622.HK trades at HK$3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6622.HK's P/E ratio is -6.40. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6622.HK's ROE of -0.12%. Regarding short-term risk, 2509.HK is more volatile compared to 6622.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6978.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6978.HK has a market cap of 1.6B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6978.HK trades at HK$3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6978.HK's P/E ratio is -8.10. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6978.HK's ROE of -0.01%. Regarding short-term risk, 2509.HK is less volatile compared to 6978.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1875.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1875.HK has a market cap of 1.5B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1875.HK trades at HK$1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1875.HK's P/E ratio is 39.20. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1875.HK's ROE of +0.05%. Regarding short-term risk, 2509.HK is more volatile compared to 1875.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2511.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2511.HK has a market cap of 1.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2511.HK trades at HK$2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2511.HK's P/E ratio is -2.87. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2511.HK's ROE of -0.00%. Regarding short-term risk, 2509.HK is less volatile compared to 2511.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6998.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6998.HK has a market cap of 1.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6998.HK trades at HK$2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6998.HK's P/E ratio is -23.09. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6998.HK's ROE of -0.05%. Regarding short-term risk, 2509.HK is more volatile compared to 6998.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2137.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2137.HK has a market cap of 1.3B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2137.HK trades at HK$1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2137.HK's P/E ratio is -2.38. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2137.HK's ROE of -0.18%. Regarding short-term risk, 2509.HK is more volatile compared to 2137.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1244.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1244.HK has a market cap of 1B. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1244.HK trades at HK$4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1244.HK's P/E ratio is -5.22. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1244.HK's ROE of -0.22%. Regarding short-term risk, 2509.HK is more volatile compared to 1244.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2496.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2496.HK has a market cap of 820M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2496.HK trades at HK$4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2496.HK's P/E ratio is -7.83. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2496.HK's ROE of -3.00%. Regarding short-term risk, 2509.HK is more volatile compared to 2496.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2126.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2126.HK has a market cap of 757.3M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2126.HK trades at HK$1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2126.HK's P/E ratio is -1.17. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2126.HK's ROE of -0.45%. Regarding short-term risk, 2509.HK is more volatile compared to 2126.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2185.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2185.HK has a market cap of 737.8M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2185.HK trades at HK$3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2185.HK's P/E ratio is -8.03. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2185.HK's ROE of -0.13%. Regarding short-term risk, 2509.HK is less volatile compared to 2185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 6628.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 6628.HK has a market cap of 676.1M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 6628.HK trades at HK$1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 6628.HK's P/E ratio is -1.91. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 6628.HK's ROE of -0.35%. Regarding short-term risk, 2509.HK is more volatile compared to 6628.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 9939.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 9939.HK has a market cap of 629.6M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 9939.HK trades at HK$1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 9939.HK's P/E ratio is -3.72. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 9939.HK's ROE of +0.00%. Regarding short-term risk, 2509.HK is more volatile compared to 9939.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 0690.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 0690.HK has a market cap of 500.1M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 0690.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 0690.HK's P/E ratio is 8.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 0690.HK's ROE of +0.26%. Regarding short-term risk, 2509.HK is more volatile compared to 0690.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2257.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2257.HK has a market cap of 391.2M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2257.HK trades at HK$3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2257.HK's P/E ratio is -0.72. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2257.HK's ROE of +71.56%. Regarding short-term risk, 2509.HK is more volatile compared to 2257.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 2197.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 2197.HK has a market cap of 316.5M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 2197.HK trades at HK$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 2197.HK's P/E ratio is -0.32. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 2197.HK's ROE of +0.73%. Regarding short-term risk, 2509.HK is more volatile compared to 2197.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 8158.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 8158.HK has a market cap of 109.5M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 8158.HK trades at HK$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 8158.HK's P/E ratio is 6.00. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 8158.HK's ROE of +0.71%. Regarding short-term risk, 2509.HK is more volatile compared to 8158.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2509.HK.
2509.HK vs 1228.HK Comparison
2509.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2509.HK stands at 3.3B. In comparison, 1228.HK has a market cap of 63.3M. Regarding current trading prices, 2509.HK is priced at HK$14.80, while 1228.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2509.HK currently has a P/E ratio of -8.55, whereas 1228.HK's P/E ratio is -0.13. In terms of profitability, 2509.HK's ROE is -1.12%, compared to 1228.HK's ROE of +1.17%. Regarding short-term risk, 2509.HK is less volatile compared to 1228.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2509.HK.